Vulnerable Plaque 분당서울대학교병원 심장센터 연 태 진. Causes / mediators of atherothrombosis Endothelial dysfunction Fatty streak Fibrous plaque Unstable Fibrous plaque.

Slides:



Advertisements
Similar presentations
MRI and MRA of the Carotid Arteries
Advertisements

Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.
Atherosclerosis.
Pathogenesis of Acute Coronary Syndromes Nathan Wong
ATHEROMA: MORPHOLOGY and EFFECTS
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
BY Dr Ola Omran Pathology Department. objectives 1.Define & classify Arteriosclerosis 2.Emphasize the clinical importance of the arteriosclerosis 3.List.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
PBL CV 2 Pathophysiology of coronary artery disease.
Acute Coronary Syndromes and The Inflammation Theory: Fact or Fiction Rabih R. Azar, MD, MSc, FACC Associate Professor of Medicine Saint-Joseph University.
ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.
ATHEROSCLEROSIS Sufia Husain. Pathology. KSU. Riyadh. March 2015
Aging of the Cardiovascular System (continued)
Extracellular cholesterol and cholesterol-filled macrophages (foam cells) accumulate in subendothelial space. Subsequent structural modifications of LDL.
ATHEROSCLEROSIS By Joshua Bower Easter Revision 2014
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
PATHOLOGY OF VASCULAR OCCLUSION, ATHEROSCLEROSIS, HYPERTENSION AND LYMPHEDEMA.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
ATHEROSCLEROSIS Dr. Gehan mohamed
Dr Azra Parveen Senior Registrar Medicine. Acute myocardial infarction is the rapid development of myocardial necrosis caused by a critical imbalance.
Atherosclerosis  hardening of the arteries due to the deposition of atheromas  heart disease is the leading cause of death  caused by the deposition.
PRESENTED BY : FATHIMA SHAIK ROLL# 1431 MD 04.  WHAT IS ATHEROSCLEROSIS?  CAUSES  PATHOGENESIS  SIGNS AND SYMPTOMS  COMPLICATIONS  DIAGNOSIS  TREATMENT.
1 State of the art in Detection of Vulnerable Plaques Presented by : Shahryar Rahnamayan Ph.D. student Supervisors : Prof. H. R. Tizhoosh Prof. M. Salama.
Lipoprotein Structures, Function and Metabolism (4)
The Biology of Atherosclerosis, Heart Attacks and Strokes
Atherosclerosis Hisham Al Khalidi. Vessel wall structure.
Atherosclerosis.
Pathophysiology of IHD
Ischaemic Heart Disease (Coronary Artery Disease)
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 17 Disorders of Blood Flow and Blood Pressure.
Atherosclerosis: a bioengineer’s perspective
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
The Atherosclerotic Process The progressive __________ and hardening of the artery due to the build up of _________.
Associate professor of pathology
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis Atherosclerosis is a specific form of arteriosclerosis (thickening & hardening of arterial walls) affecting primarily the intima of large.
Week 6: Cardiovascular Disease Processes. Outline Structure and function of blood vessels –Differences between arteries and veins Pathophysiology of atherosclerosis.
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
ATHEROSCLEROSIS DR.SAMINA QAMAR ASSISTANT PROFESSOR HISTOPATHOLOGY.
Cardiovascular disease 1/Pathology of cardiovascular disease (CVD) - Effect of artherosclerosis and its links to cardiovascular disease (CVD) - Thrombosis.
New techniques for the “invasive diagnosis” of the vulnerable plaque Antwerp, 17 March 2006.
VASCULAR DISEASE Atherosclerosis Jagdish Butany,MBBS,MS,FRCPC, Prof. Dept Lab Med & Pathobiol., Pathologist, UHN-Toronto Gen/Hosp
ATHEROSCLEROSIS. Institute of Pathological Physiology Martin Vokurka Winter Semester 2007/08.
순환기질환 - 혈관, 림프관 -.
1 Atherosclerosis ISCHEMIC CHEART DISEASE. 2 Atherosclerosis ATHEROSCLEROSIS IS THE CHRONIC DISEASE WITH THE LIPID AND PROTEIN ABNORMAL METABOLISMS, WITH.
R4 하 상 진. Introduction Circulation May 1;115(17):
Is atherosclerosis a metabolic disease?
Use of OCT to Localize Macrophages
CLS 223.
Chapter 6 The disease of cardiovascular system
Should we Use OCT in STEMI Patients?
Plaque rupture, thrombosis, and healing. A
Section 3: Role of lipids in endothelial function
Vulnerable Atherosclerotic Carotid Plaque Evaluation by Ultrasound, Computed Tomography Angiography, and Magnetic Resonance Imaging: An Overview  Cyrille.
Advanced Nutrition Diet and Cardiovascular Disease 1
Chapter 12 Pathophysiology of Atherosclerosis
Arterial wall: structure and function
Section 4: Plaque dynamics and stenosis
Diabetes and atherosclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Atherosclerosis Dr:HAMED ALGHAMDI.
The Biological Role of Inflammation in Atherosclerosis
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Presentation transcript:

Vulnerable Plaque 분당서울대학교병원 심장센터 연 태 진

Causes / mediators of atherothrombosis Endothelial dysfunction Fatty streak Fibrous plaque Unstable Fibrous plaque Plaque rupture/ fissure & thrombosis Acute coronary syndrome Cardiovascular death Ross R. NEJM 1999; 340: Inflammation Vascular risk factors Genes, BP, Smoking, Chol., Diabetes Upregulation of adhesion molecules  permeability to pl. lipoproteins (NO, A II, PDGF) Leucocytes migrate into artery wall (ox. LDL, PDGF) Lipid-laden macrophages (foam cells) T lymphocyte activation Smooth muscle cells migrate & lipid laden Fibrous cap Necrotic core (apoptosis of lipid & WBC) Expansion at shoulders as leucocytes adhere & enter (ox. LDL, PDGF) Thinning/fissuring of fibrous cap Large, lipid core Influx & activation of macrophages - release metalloproteinases Haemorrhage from - vasa vasorum - lumen of artery …… …….. Atherogenesis Atherothrombosi Angina

Stable and Rupture-prone plaque

Rupture of a coronary plaque The fibrous cap ruptures and the lipid core is exposed to the blood stream

Platelets aggregate around the exposed lipid core and initiate thrombus formation Rupture of a coronary plaque- Thrombosis

Thrombosis propagation v v

Underlying pathology of acute coronary syndrome (unstable angina, acute MI) and sudden cardiac death

 Ruptured plaques (~ 70%) Stenotic (~ 20%) Nonstenotic (~ 50%)  Nonruptured plaques (~ 30%) Erosion Calcified nodule Others/Unknown *Adapted from Falk and associates,6 Davies,7 and Virmani and colleagues.7 Underlying Pathologies of "Culprit" Coronary Lesions Naghavi et al. Circulation. 2003;108:1664

Different Types of Vulnerable Plaques Major Underlying Cause of Acute Coronary Events Normal Rupture-prone Fissured Eroded Critical Stenosis Hemorrhage

Rupture-prone plaque

Eroded plaque with thrombosis

Calcified nodule

The Challenge of Terminology  Culprit Plaque; A Retrospective Term  Vulnerable Plaque; A Prospective Term  Vulnerable Plaque (high-risk plaque) = Future Culprit Plaque  좁은 의미 : Rupture-prone plaque  넓은 의미 : Plaque that is at increased risk of thrombosis and rapid stenosis progression Naghavi et al. Circulation. 2003;108:1664

Criteria for Defining Vulnerable Plaque Based on the Study of Culprit Plaques  Major criteria. Active inflammation (monocyte/macrophage and sometimes T- cell infiltration). Thin cap with large lipid core. Endothelial denudation with superficial platelet aggregation. Fissured plaque. Stenosis 90%  Minor criteria. Superficial calcified nodule. Glistening yellow. Intraplaque hemorrhage. Endothelial dysfunction. Outward (positive) remodeling

Markers of Vulnerability at the Plaque/Artery Level  Plaque Morphology/Structure. Plaque cap thickness. Plaque lipid core size. Plaque stenosis (luminal narrowing). Remodeling (expansive vs constrictive remodeling). Color (yellow, glistening yellow, red, etc). Collagen content versus lipid content, mechanical stability (stiffness and elasticity). Calcification burden and pattern (nodule vs scattered, superficial vs deep, etc). Shear stress (flow pattern throughout the coronary artery)

 Activity/Function. Plaque inflammation (macrophage density, rate of monocyte infiltration and density of activated T cell). Endothelial denudation or dysfunction (local NO production, anti-/procoagulation properties of the endothelium). Plaque oxidative stress. Superficial platelet aggregation and fibrin deposition (residual mural thrombus). Rate of apoptosis (apoptosis protein markers, coronary microsatellite, etc). Angiogenesis, leaking vasa vasorum, and intraplaque hemorrhage. Matrix-digesting enzyme activity in the cap (MMPs 2, 3, 9, etc). Certain microbial antigens (eg, HSP60, C. pneumoniae) Markers of Vulnerability at the Plaque/Artery Level

 Pan-Arterial. Transcoronary gradient of serum markers of vulnerability. Total coronary calcium burden. Total coronary vasoreactivity (endothelial function). Total arterial burden of plaque including peripheral (eg, carotid IMT) Markers of Vulnerability at the Plaque/Artery Level

Diagnostic technique

Intravascular Ultrasound (IVUS)  Advantage:  Reveals the morphology of the plaque  Disadvantages:  Low spatial resolution (~ 200  m)  Limited information about the plaque composition

IVUS

IVUS-radiofrequency data Virtual histologyElastography

Morphological Lesion size Lesion shape % Stenosis Cap thickness Chemical Lipid, Protein, Water Calcium Collagen Physiological Flow disturbances CFR, FFR Spectroscopy Polarization Grey Scale (2-D, L-Mode) Doppler  infrared light wave reflection Optical Coherence Tomography (OCT)

lp Homogeneous, Signal-rich Fibrous Lipid Echolucent, Diffuse Borders Echolucent, Sharp Borders Calcific 500 µm OCT characteristics

Histology OCT High lipid content Fibro-fatty plaque Thin Cap OCT

 Advantage:  High resolution  improved visualization of fibrous caps and plaque components  Possibility to detect inflammation  Disadvantages:  Limited penetration OCT

Angioscopy

 Advantages:  Direct visualization of the plaque surface  Disadvantages:  Visualizes only the surface of the plaque  Requires a proximal occluding balloon  Subjective interpretation Angioscopy

Intravascular Thermography

 Advantages:  Gives information about plaque inflammation  Disadvantages:  Overlap in temperature heterogeneity b/w stable and unstable presentations  Plaque temperature may be affected by the blood flow

Spectroscopy  Advantage:  Chemical compounds detection  Disadvantage:  lack of structural definition  may needs combination with imaging techniques  Analyze the light scattered from the tissue

Others  Intravascular MRI  Intravascular nuclear imaging  MRI  Electron Beam Computed Tomography (EBCT)

Therapeutic options  Focal  Regional  Systemic: medical tx. (aspirin, statins, beta-blocker, ACE inhibitor …..) PCI in selected case Under investigations cryoplasty sonotherapy photodynamic therapy …..